9 completed, 1 recruiting, 1 unknown. 4 Phase 1, 4 Phase 4, 2 Not applicable.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 4 | Completed 4 |
| Phase 4 | 4 | Completed 3, Unknown 1 |
| Not applicable | 2 | Completed 1, Recruiting 1 |
Follow Pneumococcal Pneumonia: new trials by email Literature Review of Pneumococcal Pneumonia trials Research Report on Pneumococcal Pneumonia
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Artificial Intelligence-driven Virtual Standardized Pediatric Patients Trial Virtual standardized patients (VSPs), Case teaching manuals, Case teaching videos - Pneumococcal Pneumonia, Rotavirus Enteritis With Hypovolemic Shock | Not applicable | Recruiting | Southern Medical University, China | 459 | 2024-12-01 | 2024-12-19 |
| Pneumococcal Community-Acquired Pneumonia Requiring Hospitalization Among Colombian Adults Community Acquired Pneumonia (CAP), Pneumococcal Pneumonia | Completed | Universidad de la Sabana | 688 | 2022-06-28 | 2026-01-21 | |
| Pharmacist Impact on Pneumococcal Polysaccharide Vaccination Rates in Patients With Diabetes in a Supermarket Pharmacy Chain Pharmacist Vaccine Education - Pneumococcal Pneumonia | Not applicable | Completed | Virginia Commonwealth University | 431 | 2018-11-01 | 2019-03-15 |
| Pneumococcal Vaccination of Multiple Myeloma Patients on Novel Agents Vaccination with pneumococcal conjugate vaccine (PCV13), Standard Antibacterial Prophylaxis - Multiple Myeloma, Pneumococcal Infection | Phase 4 | Completed | Minsk Scientific-Practical Center for Surgery, Transplantation and Hematology | 36 | 2018-07-01 | 2022-08-31 |
| Phase I to Test a New Pneumococcal Vaccine Bioconjugate pneumococcal vaccine, Multivalent plain polysaccharide vaccine - Pneumococcal Pneumonia, Pneumonia, Bacterial | Phase 1 | Completed | LimmaTech Biologics AG | 72 | 2017-09-07 | 2018-12-04 |
| The Immunogenicity of Simultaneous Administration of Quadrivalent Influenza Vaccine and 23-valent Pneumococcal Vaccine Simultaneous administration of Pneumovax NP® and Fluvic HA syringe®, Sequential administration of Pneumovax NP® and Fluvic HA syringe® - Pneumococcal Pneumonia, Influenza | Phase 4 | Completed | Kameda Medical Center | 162 | 2015-11-01 | 2019-01-31 |
| Study of an Investigational Pneumococcal Vaccine at Three Dose Levels in Healthy Adults Pneumococcal vaccine Formulation 1, Pneumococcal vaccine Formulation 2, Pneumococcal vaccine Formulation 3 - Pneumococcal Infections, Streptococcus Pneumoniae Infections | Phase 1 | Completed | Sanofi Pasteur, a Sanofi Company | 100 | 2010-06-01 | 2015-03-18 |
| Study of Two Investigational Pneumococcal Vaccines in Healthy Adults Pneumococcal Vaccine Formulation 1, Pneumococcal Vaccine Formulation 2, Pneumococcal Vaccine Formulation 3 - Pneumococcal Infections, Streptococcus Pneumoniae Infections | Phase 1 | Completed | Sanofi | 131 | 2010-02-01 | 2011-09-30 |
| PCV10 Reactogenicity and Immunogenicity Study - Malindi PCV10 and DTaP, hepatitis A vaccine, DTaP, PCV10 - Pneumococcal Pneumonia | Phase 4 | Unknown | KEMRI-Wellcome Trust Collaborative Research Program | 600 | 2010-01-01 | 2018-02-23 |
| Study of an Investigational Pneumococcal Vaccine in Healthy Adult Volunteers Pneumococcal Vaccine - Pneumococcal Infections, Pneumococcal Pneumonia | Phase 1 | Completed | Sanofi | 63 | 2007-02-01 | 2011-09-30 |
| Targeting of Immune Response After Pneumococcal Vaccination Pneumococcal polysaccharide vaccine, pneumococcal conjugate vaccine - Pneumococcal Pneumonia | Phase 4 | Completed | Helsinki University Central Hospital | 42 | 2005-01-01 | 2011-07-26 |
Pneumonia, Pneumococcal (11) · Pneumococcal Infections (4) · Appendicitis (1) · Community-Acquired Pneumonia (1) · Febrile Neutropenia (1) · Hand, Foot and Mouth Disease (1) · Influenza, Human (1) · Multiple Myeloma (1) · Pneumonia (1) · Pneumonia, Bacterial (1) · Respiratory Insufficiency (1)
Bacterial Infections (11) · Bacterial Infections and Mycoses (11) · Gram-Positive Bacterial Infections (11) · Infections (11) · Lung Diseases (11) · Respiratory Tract Diseases (11) · Respiratory Tract Infections (11) · Streptococcal Infections (11) · Pneumonia (10) · Pneumonia, Bacterial (10) · Pneumococcal Infections (7) · RNA Virus Infections (2) · Virus Diseases (2) · Agranulocytosis (1) · Blood Protein Disorders (1)
Pneumococcal Vaccines (3) · 10-valent pneumococcal conjugate vaccine (1) · Hepatitis A Vaccines (1) · Heptavalent Pneumococcal Conjugate Vaccine (1) · PHiD-CV vaccine (1) · Vaccination (1)
Sanofi (2) · Helsinki University Central Hospital (1) · KEMRI-Wellcome Trust Collaborative Research Program (1) · Kameda Medical Center (1) · LimmaTech Biologics AG (1) · Minsk Scientific-Practical Center for Surgery, Transplantation and Hematology (1) · Sanofi Pasteur, a Sanofi Company (1) · Southern Medical University, China (1) · Universidad de la Sabana (1) · Virginia Commonwealth University (1)
Switzerland (3) · Belarus (1) · China (1) · Colombia (1) · Finland (1) · Germany (1) · Japan (1) · Kenya (1) · United States (1)
Anatoly Uss, MD/PhD (1) · Anu Kantele, MD PhD (1) · Cristian C Serrano, MD, cPhD (1) · Jean-Venable Goode, Pharm.D., BCPS, FAPhA, FCCP (1) · Kei Nakashima, MD (1) · Laura Hammitt, MD (1) · Luis F Reyes, MD,PhD, MsC (1) · Michael Leidig, MD (1) · Yao Zhao, Doctor (1)
PMID 23123106, PMID 23131206, PMID 23153437, PMID 24465570, PMID 26083474, PMID 29561248, PMID 32192948, PMID 32418789, PMID 40396505